Clinical Trial Update: A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer [Phase 3]

View source ↗

Summary

This entry reports a Phase 3 trial of ixabepilone as second-line therapy for locally advanced, recurrent, or metastatic endometrial cancer, which was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Ixabepilone (Ixempra) (ixabepilone)

Snippet

Sponsor: R-Pharm | Conditions: Endometrial Cancer | Phase 3 | Status: TERMINATED | Results posted: 2014-03-14